Fund · IBB · ETF
iShares Biotechnology ETF
Managed by BlackRock iShares. Net assets $9.09B at 30 Jun 2026.
Top 10 holdings
The 10 largest are 54.3% of net assets, out of 50 holdings
11.66%
BlackRock Funds III · US
8.08%
Vertex Pharmaceuticals, Inc. · US
7.83%
Amgen, Inc. · US
6.84%
4.91%
3.76%
Argenx SE · NL
3.12%
2.89%
Natera, Inc. · US
2.78%
2.47%
Biogen, Inc. · US
Source: SEC Form N-PORT, period ended 30 Jun 2026
The fund
- Ticker
- IBB
With a free account
A free account opens 10 full pages a month and lets you follow this page: every holding, changes since the last filing, country and sector exposure, country risk of the holdings, exports to Excel.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.